New aortic valve replacement device safety study
Part of Heart & circulation clinical trials.
This trial tests how safe and effective a new artificial aortic valve (Venus-Neo) is for people who need an aortic valve replacement. It may help by offering another option, while researchers closely track outcomes after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old
- A heart specialist has told you that you need an aortic valve replacement
- You can and agree to attend follow-up visits and sign consent paperwork
- You have not had any prior valve replacement or open-heart valve repair
- You have not had recent heart procedures or major heart surgery that would interfere with this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a new replacement heart valve works and how safe it is. You might qualify if you need a planned first-time aortic valve replacement and are 60-70 years old (or younger if you cannot take blood thinners).
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This study tracks how well a new artificial aortic valve and aorta graft (called KONECT RESILIA) work after surgery in real-world patients. Researchers want to understand if it's safe and performs well over time in people who need this valve replaced.
This study tests a new biological heart valve called 'UniLine' for people who need to replace their mitral valve (the valve between the left heart chambers) or aortic valve (the main valve sending blood to the body) for the first time. If you qualify, you would have planned surgery (not an emergency) and need to be free of certain other serious health conditions.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
Hear when a new Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.